
Results
132
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
132 companies
Covalon Technologies
Market Cap: CA$64.6m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
COV
CA$2.36
7D
4.4%
1Y
-10.3%
Cipher Pharmaceuticals
Market Cap: CA$355.6m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$14.14
7D
-19.4%
1Y
-0.6%
BioSyent
Market Cap: CA$171.7m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$15.25
7D
1.7%
1Y
33.8%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.05
7D
4.7%
1Y
-5.7%
Charlotte's Web Holdings
Market Cap: CA$111.2m
Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.
CWEB
CA$0.41
7D
18.6%
1Y
159.4%
Bright Minds Biosciences
Market Cap: CA$1.1b
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$107.34
7D
-3.3%
1Y
79.0%
Vaxil Bio
Market Cap: CA$637.4k
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.16
7D
-8.6%
1Y
0%
Cronos Group
Market Cap: CA$1.6b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$4.36
7D
0.9%
1Y
32.5%
Knight Therapeutics
Market Cap: CA$904.7m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$9.32
7D
-4.5%
1Y
49.8%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
-8.3%
High Tide
Market Cap: CA$284.7m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.26
7D
2.2%
1Y
-11.4%
Auxly Cannabis Group
Market Cap: CA$305.0m
Operates as a consumer-packaged goods company in the cannabis products market in Canada.
XLY
CA$3.05
7D
7.0%
1Y
36.2%
1CM
Market Cap: CA$16.5m
A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.
EPIC
CA$0.14
7D
-3.3%
1Y
-46.3%
Organigram Global
Market Cap: CA$246.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.69
7D
23.4%
1Y
-15.9%
Sweet Earth Holdings
Market Cap: CA$6.6m
Does not have significant operations.
SE
CA$0.51
7D
0%
1Y
410.0%
SOL Global Investments
Market Cap: CA$1.1m
A private equity firm specializing in emerging growth.
SOL
CA$0.04
7D
0%
1Y
-94.3%
Aurora Cannabis
Market Cap: CA$341.8m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$5.11
7D
23.1%
1Y
-27.0%
Eupraxia Pharmaceuticals
Market Cap: CA$608.8m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.31
7D
-1.6%
1Y
26.3%
Curaleaf Holdings
Market Cap: CA$3.6b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$13.14
7D
1.5%
1Y
19.0%
Entheon Biomedical
Market Cap: CA$831.5k
Operates as a biotechnology research and development company.
ENBI.X
CA$0.06
7D
0%
1Y
-36.8%
Avant Brands
Market Cap: CA$9.8m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.62
7D
6.9%
1Y
-28.7%
BriaCell Therapeutics
Market Cap: CA$41.8m
A pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$4.73
7D
-6.7%
1Y
-55.0%
Simply Solventless Concentrates
Market Cap: CA$6.9m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.065
7D
30.0%
1Y
-81.4%
Satellos Bioscience
Market Cap: CA$288.5m
A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
MSCL
CA$13.38
7D
-2.5%
1Y
89.0%
Cresco Labs
Market Cap: CA$502.3m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.10
7D
4.8%
1Y
-16.7%
Rubicon Organics
Market Cap: CA$31.1m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.44
7D
-20.0%
1Y
-18.5%
NurExone Biologic
Market Cap: CA$44.7m
A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.
NRX
CA$0.47
7D
-4.0%
1Y
-38.3%
TerrAscend
Market Cap: CA$301.9m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.81
7D
11.0%
1Y
-31.9%
Canopy Growth
Market Cap: CA$596.5m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.38
7D
0.7%
1Y
-23.3%
Noveris Health Sciences
Market Cap: CA$17.3m
A biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality.
NVRS
CA$0.22
7D
-36.2%
1Y
-56.0%
COSCIENS Biopharma
Market Cap: CA$8.3m
A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally.
CSCI
CA$7.88
7D
11.8%
1Y
-33.5%
Thiogenesis Therapeutics
Market Cap: CA$39.9m
A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.
TTI
CA$0.55
7D
0%
1Y
-30.4%
Medicenna Therapeutics
Market Cap: CA$36.9m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.46
7D
22.7%
1Y
-57.4%
Light AI
Market Cap: CA$29.4m
A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.
ALGO
CA$0.24
7D
14.3%
1Y
-7.7%
Neurothera Labs
Market Cap: CA$27.6m
Engages in the development of a portfolio of drugs based on cannabinoid molecules.
NTLX
CA$0.33
7D
12.1%
1Y
n/a
1933 Industries
Market Cap: CA$5.2m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.01
7D
0%
1Y
100.0%